Upstream Bio (UPB) Interest & Investment Income (2023 - 2026)

Upstream Bio's Interest & Investment Income history runs 4 years deep, the most recent figure standing at $3.1 million for Q1 2026.

• In Q1 2026, Interest & Investment Income fell 35.61% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $15.2 million (down 2.28% YoY), while the FY2025 annual figure was $16.9 million, up 39.68% from the prior year.
• Interest & Investment Income was $3.1 million for Q1 2026 at Upstream Bio, down from $3.7 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $5.1 million in Q4 2024 to a low of $1.3 million in Q1 2024.
• Historically, Interest & Investment Income has averaged $3.2 million across 4 years, with a median of $3.1 million in 2026.
• The sharpest annual moves came in 2025 and 2026: Interest & Investment Income soared 274.64% in 2025, then plunged 35.61% in 2026.
• A 4-year view of Interest & Investment Income shows it stood at $1.5 million in 2023, then jumped by 234.17% to $5.1 million in 2024, then declined by 28.01% to $3.7 million in 2025, then fell by 16.42% to $3.1 million in 2026.
• The last three Interest & Investment Income figures came in at $3.1 million (Q1 2026), $3.7 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.